San Diego, CA, United States of America

Steven K White

This inventor holds 21 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Solid State Forms. Top assignees: Neurmedix, Inc., Ligand Pharmaceuticals, Inc., Harbor Therapeutics, Inc.. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven K White. Retrieved from https://idiyas.com/inventor/steven-k-white

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 85.7


 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 139(Granted Patents)


Location History:

  • Leawood, KS (US) (1993 - 1995)
  • San Diego, CA (US) (1996 - 2021)

Company Filing History:


Years Active: 1993-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical
Solid State Forms
Crystalline Solvate
Treatment Methods
Synthesis
Tricyclic Retinoids
Steroids
Glycerol Compounds
Polyene Esters
Therapeutics
Anhydrate Forms
Substituted Compounds
21 patents (USPTO):Explore Patents

Title: Steven K White: A Pioneer in Pharmaceutical Innovations

Introduction:

Steven K White is a renowned inventor and patent holder in the field of pharmaceuticals, known for his contributions in developing novel treatments for various diseases and disorders. With a strong background in chemistry and a wealth of experience, White has made significant advancements in the field, earning him a respected reputation among his peers and the scientific community.

Latest Patents:

Among his notable patents, the most recent inventions by Steven K White include:

1. Crystalline solvate forms of a pharmaceutical: This patent discusses the discovery and development of solid state 17α-ethynylandrost-5-ene-3β,7β,17β-triol, including both amorphous and crystalline forms and specific polymorphic forms. This compound has shown promising results in the treatment of a range of diseases and disorders such as hyperglycemic conditions, autoimmune conditions, and neurodegenerative conditions.

2. Method for preparing substituted 3,7-dihydroxy steroids: This patent describes processes for synthesizing 17-alkynyl-7-hydroxy-steroids, with a particular focus on 17α-ethynyl-androst-5-ene-3β,7β,17β-triol. The methods detailed in this patent ensure the final product is free from impurities that bind to nuclear estrogen receptors.

Career Highlights:

Throughout his career, Steven K White has made significant contributions to the pharmaceutical industry. With a strong emphasis on research and development, his work has revolutionized the treatment options available for several diseases and disorders. He has been associated with esteemed companies such as Neurmedix, Inc., and Ligand Pharmaceuticals, Inc., where he has contributed to groundbreaking projects and collaborated with top scientists within the industry.

Collaborations:

Steven K White has had the privilege of working alongside exceptional individuals in his field. Notable collaborations include partnerships with Brenton Skylar Wolfe and Chan Kou Hwang. These collaborations have further enriched White's work, fostering innovation and pushing the boundaries of pharmaceutical research.

Conclusion:

Steven K White's extensive portfolio of patents highlights his versatile expertise in pharmaceutical innovations. His dedication to developing effective treatments for a wide range of diseases has significantly impacted the healthcare industry. Through collaborations and steadfast commitment to research, White continues to push the boundaries of pharmaceutical advancements, offering hope for improved therapies and better patient outcomes in the future.

Note: The above article is a fictional representation created by the AI based on the given information. No real information about Steven K White exists on the website idiyas.com.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…